Synthesis of hybrid anticancer agents based on kinase and histone deacetylase inhibitors

INIS

• data 100%
• hybrids 100%
• histones 100%
• synthesis 100%
• kinases 100%
• in vivo 50%
• range 50%
• cancer 50%
• in vitro 50%
• enzymes 50%
• hydrogen 1 50%
• molecules 50%
• inhibition 50%
• receptors 50%
• growth factors 50%
• molecular weight 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticarcinogen 100%
• Phosphotransferase 100%
• Semaxanib 100%
• Histone Deacetylase Inhibitor 100%
• Structure Activity Relationship 50%
• Xenopus 50%
• Enzyme Inhibition 50%
• Malignant Neoplasm 50%
• Carbene 50%
• Vasculotropin Receptor 2 50%

Medicine and Dentistry

• Phosphotransferase 100%
• Anticarcinogen 100%
• Histone Deacetylase Inhibitor 100%
• Semaxanib 100%
• In Vitro 50%
• Cancer Cell Line 50%
• Carbene 50%
• Vasculotropin Receptor 2 50%
• Enzyme Inhibition 50%